Lilly's New Drug Could Be the Key to Wining Insurance Coverage

Jeff says that broadening the use of Lilly's new drug could be the key to winning insurance coverage. Obesity today is not broadly reimbursed, right? Only for bariatric surgery and then you have to prove that you've been unsuccessful in various efforts to lose weight. Jeff: If payers become really restrictive on obesity as the lead indication, well, then it could be approved for sleep apnea or chronic kidney disease or heart failure or NASH.